Comparison of p53 and prohibitin expression in the spectrum of hepatitis, cirrhosis, and hepatocellular carcinoma (2017)
- Authors:
- USP affiliated authors: RAMALHO, FERNANDO SILVA - FMRP ; OLIVEIRA, CARLOS AUGUSTO FERNANDES DE - FZEA ; SILVA, DEISY MARA DA - FMRP ; AUGUSTO, MARLEI JOSIELE - FMRP ; RAMALHO, LEANDRA NAIRA ZAMBELLI - FMRP
- Unidades: FMRP; FZEA
- DOI: 10.20517/2394-5079.2016.39
- Subjects: HEPATITE; CIRROSE HEPÁTICA; CARCINOMA HEPATOCELULAR; APOPTOSE; NEOPLASIAS HEPÁTICAS
- Language: Inglês
- Imprenta:
- Publisher place: Alhambra, CA
- Date published: 2017
- Source:
- Título do periódico: Hepatoma Research
- Volume/Número/Paginação/Ano: v. 3, p. 34-42, 2017
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by-nc-sa
-
ABNT
DELLA PORTA, Lívia Maria et al. Comparison of p53 and prohibitin expression in the spectrum of hepatitis, cirrhosis, and hepatocellular carcinoma. Hepatoma Research, v. 3, p. 34-42, 2017Tradução . . Disponível em: https://doi.org/10.20517/2394-5079.2016.39. Acesso em: 19 abr. 2024. -
APA
Della Porta, L. M., Ramalho, F. S., Oliveira, C. A. F. de, Silva, D. M. da, Augusto, M. J., & Ramalho, L. N. Z. (2017). Comparison of p53 and prohibitin expression in the spectrum of hepatitis, cirrhosis, and hepatocellular carcinoma. Hepatoma Research, 3, 34-42. doi:10.20517/2394-5079.2016.39 -
NLM
Della Porta LM, Ramalho FS, Oliveira CAF de, Silva DM da, Augusto MJ, Ramalho LNZ. Comparison of p53 and prohibitin expression in the spectrum of hepatitis, cirrhosis, and hepatocellular carcinoma [Internet]. Hepatoma Research. 2017 ; 3 34-42.[citado 2024 abr. 19 ] Available from: https://doi.org/10.20517/2394-5079.2016.39 -
Vancouver
Della Porta LM, Ramalho FS, Oliveira CAF de, Silva DM da, Augusto MJ, Ramalho LNZ. Comparison of p53 and prohibitin expression in the spectrum of hepatitis, cirrhosis, and hepatocellular carcinoma [Internet]. Hepatoma Research. 2017 ; 3 34-42.[citado 2024 abr. 19 ] Available from: https://doi.org/10.20517/2394-5079.2016.39 - Nonalcoholic steatohepatitis: a search for factual animal models
- Riboflavin (vitamin B-2) reduces hepatocellular injury following liver ischaemia and reperfusion in mice
- Rosmarinic acid attenuates hepatic ischemia and reperfusion injury in rats
- Effect of gallic acid on regression of murine CCL4-induced hepatic cirrhosis
- Oncogenic and tumor suppressor pathways in subchronic aflatoxicosis in rats: association with serum and urinary aflatoxin exposure biomarkers
- Inhibition of hepatocarcinogenesis by ArtinM via anti-proliferative and pro-apoptotic mechanisms
- Aflatoxin B1 residues in human livers and their relationship with markers of hepatic carcinogenesis
- Incidence of aflatoxin B1 residues in human liver samples from patients with cirrhosis and hepatocellular carcinoma in Brazil
- Molecular changes related to hepatocarcinogenesis in subchronic aflatoxicosis in rats
- Lectin artinm as a anticarcinogenic agent on Afb1-induced hepatocarcinogenesis in rats
Informações sobre o DOI: 10.20517/2394-5079.2016.39 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
